MEDEPHARM, s. r. o.Active
People and shareholders
Executive director (konateľ) · 2023
Executive director (konateľ) · 2022
Shareholder · 5 000 € · 2022
Former persons (6)
Executive director (konateľ) · 2022–2023
Executive director (konateľ) · 2021–2022
Shareholder · 2022–2022
Shareholder · 2022–2022
Shareholder · 2021–2022
Shareholder · 2021–2022
Source: Register of Legal Entities (Statistical Office SR). Only name and position are shown — no address or date of birth.
Key figures
Key figures
2025Balance sheet structure
Summary of annual reports2021–2025
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Balance sheet — assets | |||||
| Total current assets | 4 836 | 205 075 | 348 700 | 487 085 | 420 240 |
| Total non-current assets | 0 | 104 868 | 90 748 | 69 219 | 61 996 |
| Total assets | 4 836 | 310 292 | 439 823 | 556 713 | 483 245 |
| Balance sheet — liabilities and equity | |||||
| Total liabilities | 0 | 334 699 | 392 218 | 484 640 | 374 982 |
| Share capital | 5 000 | 5 000 | 5 000 | 5 000 | 5 000 |
| Profit for the year (equity) | -164 | -29 243 | 47 012 | 24 468 | 36 190 |
| Total equity | 4 836 | -24 407 | 47 605 | 72 073 | 108 263 |
| Income statement | |||||
| Revenue (net turnover) | 0 | 36 201 | 1 560 276 | 1 748 344 | 1 827 796 |
| Operating profit | -164 | -32 210 | 58 659 | 30 165 | 44 862 |
| EBITDA | -164 | -30 409 | 81 153 | 53 207 | 63 429 |
| Profit before income tax | -164 | -32 567 | 56 364 | 31 563 | 46 522 |
| Profit for the reporting year | -164 | -29 243 | 47 012 | 24 468 | 36 190 |
| Labour costs | 0 | 26 690 | 218 940 | 229 568 | 238 289 |
| Depreciation of non-current assets | 0 | 1 801 | 22 494 | 23 042 | 18 567 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Documents in the Register of Financial Statements13
- 2025 Úč POD · 12 pp.
- 2025 Úč POD
- 2024 Oznámenie o dátume schválenia účtovnej závierky · 1 pp.
- 2024 Úč POD · 12 pp.
- 2024 Úč POD
- 2023 Oznámenie o dátume schválenia účtovnej závierky · 1 pp.
- 2023 Úč POD · 12 pp.
- 2023 Úč POD
- 2022 Oznámenie o dátume schválenia účtovnej závierky · 1 pp.
- 2022 Úč POD · 12 pp.
- 2022 Úč POD
- 2021 Úč MUJ · 5 pp.
- 2021 Úč MUJ
Documents open directly on registeruz.sk (Ministry of Finance of the Slovak Republic).
Summary: MEDEPHARM, s. r. o.
Overview
MEDEPHARM, s. r. o. (IČO 53774591) is a limited liability company (s.r.o.). The company was incorporated in 2021 and has existed for 5 years. Registered office according to the register: Košice - mestská časť Západ. Main activity according to the Statistical Office: maloobchod so športovými potrebami (SK NACE 4763). Size category by number of employees: 5–9 employees.
People
The statutory body has 2 members. According to the register, the company has one shareholder. The registered capital is 5 000 €.
Financial results
Revenue for 2025 was 1 827 796 €, up 4,5 % on the previous year (1 748 344 €). This is the highest revenue in the reported years (2021–2025). Net profit for 2025 was 36 190 € (2,0 % of revenue). The company was profitable in 3 of the 5 reported years. Personnel costs for 2025 were 238 289 €. At the end of 2025 the company had total assets of 483 245 € and equity of 108 263 € (equity ratio 22,4 %).
Sources and freshness
Company and people data come from the Register of Legal Entities (Statistical Office SR, CC BY 4.0) and financial statements from the Register of Financial Statements (Ministry of Finance SR); icoprofil.sk updates them daily. Data as of 19. 10. 2026. Changes, averages and ratios are calculated by icoprofil.sk from open data and are not an official assessment.